Human immunodeficiency virus and liver disease: A comprehensive update
Open Access
- 6 November 2017
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 1 (10) , 987-1001
Abstract
Among persons living with human immunodeficiency virus (HIV) infection, liver disease remains a major cause of morbidity and mortality. While the etiologies are varied and often overlapping in the individual patient, the underlying mechanisms, including oxidative stress, direct activation of stellate cells, HIV interaction with hepatocytes, and bacterial translocation with systemic immune activation, seem to be unifying characteristics. Early and fully suppressive HIV antiretroviral therapy is a mainstay of management either before or concurrent with treatment of etiologic cofactors, including hepatitis C virus, hepatitis B virus, and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Significant barriers to care that still exist include liver disease recognition, appropriate linkage to care, ongoing substance abuse, and psychiatric comorbidities in the HIV‐infected population. Emerging issues in these patients include acute and chronic hepatitis E, underreported hepatitis D, and a rising incidence of hepatocellular carcinoma. (Hepatology Communications2017;1:987–1001)Keywords
Funding Information
- Gilead Sciences, Inc.
- Janssen Therapeutics, Division of Janssen Products
- Merck & Co., Inc.
- ViiV Healthcare
- Intercept Pharmaceuticals, Inc.
- Tobira Therapeutics, Inc
- National Institutes of Health (R13AI071925)
- National Institute of Allergy and Infectious Diseases
- National Institute on Drug Abuse
This publication has 131 references indexed in Scilit:
- Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care modelAIDS Research and Therapy, 2013
- High Plasma Interleukin-18 Levels Mark the Acute Phase of Hepatitis C Virus InfectionThe Journal of Infectious Diseases, 2011
- Incidence and Risk Factors for Steatosis Progression in Adults Coinfected With HIV and Hepatitis C VirusGastroenterology, 2011
- A prospective study of alcohol consumption and HIV acquisition among injection drug usersAIDS, 2011
- HIV and HCV Cooperatively Promote Hepatic Fibrogenesis via Induction of Reactive Oxygen Species and NFκBJournal of Biological Chemistry, 2011
- Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220Vaccine, 2010
- Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitutionAIDS, 2009
- Impaired Quality of the Hepatitis B Virus (HBV)-Specific T-Cell Response in Human Immunodeficiency Virus Type 1-HBV CoinfectionJournal of Virology, 2009
- Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis CGastroenterology, 2008
- Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2007